Bristol-Myers Squibb adopts OB10’s global e-Invoicing solution

OB10 today announced that it has signed an agreement with Bristol-Myers Squibb, the global biopharmaceutical company, to streamline the company’s global invoice process management. This will include OB10’s leading e-Invoicing service in addition to their enhanced services including Purchase Order delivery, Invoice Validation and Invoice Status Check.

Bristol-Myers Squibb selected OB10 due to their ability to offer a truly global
solution. Not only will Bristol-Myers Squibb benefit from tax compliant invoice receipt, but their suppliers will benefit from the enhanced features of the service. This will lead to greater efficiencies in the invoice to pay process. Another key feature of the OB10 Service includes OBactive, OB10’s best practice supplier enrolment.

With the global scope of Bristol-Myers Squibb service, it is vital that suppliers can be enrolled and supported in their local language. OB10 boasts a strong multinational team which communicates in
their language and understands the way local businesses operate; creating a global, uncomplicated support network.

This partnership further enhances OB10’s reputation as the leading e-Invoicing provider to the pharmaceutical industry. Bristol-Myers Squibb will be joining other leading pharmaceutical companies such as GlaxoSmithKline, Pfizer and Eli Lilly & Company as customers of OB10.

www.ob10.com